Gps Wealth Strategies Group, LLC Ligand Pharmaceuticals Inc Transaction History
Gps Wealth Strategies Group, LLC
- $747 Million
- Q4 2024
A detailed history of Gps Wealth Strategies Group, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 70 shares of LGND stock, worth $8,038. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70
Previous 70
-0.0%
Holding current value
$8,038
Previous $7,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
276Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$330 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$239 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$117 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$102 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$85.4 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.94B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...